Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron dose comparison for prevention of spinal anesthesia-induced shivering in cesarean section
IRCT20141009019470N81Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of granisetron in postspinal anesthesia shivering (PSAS) and Nausea and Vomiting (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Shivering, Nausea and vomiting and 1 more. Started Jul 2019; status: completed.
02
Drugs
granisetron
03
Conditions
postspinal anesthesia shivering (PSAS)Nausea and Vomiting
Beyond the preview
Go deeper on IRCT20141009019470N81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N81.